focus -WSS

focus

author：focus 2025-10-01 10:52:03 - browse：637

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Telehealth for opioid use disorder is lifesaving

knowledge

focus

WSS

New weight loss drugs vying to be the next Wegovy or Mounjaro

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

White House touts steps to stem shortages of cancer treatments

First recipient of genetically engineered pig kidney has died

Researchers on aging grapple with how to calculate biological age

Brain worms: The science behind RFK Jr.'s parasitic infection

focus

focus

focus

As demand for Covid shots wanes, Moderna seeks its next success

Long Covid needs a new name — and a new frame

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Brain worms: The science behind RFK Jr.'s parasitic infection

Malaria cases in Florida and Texas: Here’s what you need to know

Walmart eyes Medicare Advantage provider ChenMed

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA approves updated Covid vaccines

Cancer drug shortages should be causing more outrage

Brain worms: The science behind RFK Jr.'s parasitic infection

focus

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Medicare says breakthrough device reimbursement rule to come by summer

What to make of Biden’s latest efforts on cancer research

FDA approves updated Covid vaccines

Researchers on aging grapple with how to calculate biological age

knowledge

knowledge

focus

focus